HitGen closes series B round

HitGen Ltd. (Chengdu, China) raised RMB250 million ($39.1 million) in a series B round led by CDH. Also participating were Leadyond Capital and other undisclosed existing investors.

HitGen has a DNA-encoded library design, synthesis and screening drug discovery platform comprising more than 200 billion new small molecules across more than 900 libraries...